Clinical Trials Logo

Filter by:
NCT ID: NCT00709566 Active, not recruiting - Hip Osteoarthritis Clinical Trials

EMPART - Exercise and Manual Physiotherapy Arthritis Research Trial

EMPART
Start date: April 2008
Phase: Phase 3
Study type: Interventional

Hip osteoarthritis is a major cause of disability and reduced quality of life. Physiotherapy, which encompasses a range of interventions such as exercise therapy, manual therapy, education and electrophysical agents, is a core component of management. To date, exercise therapy to date has the greatest evidence of effect . However, this evidence is limited as only a short-term benefit has been identified and improvements in pain and function decline over time. There is some limited evidence for a beneficial effect of manual therapy over exercise. However, clinically these interventions are used in combination, not in isolation. To date, no research has investigated the combined effect of exercise and manual therapy in hip OA. A multi-centre randomised controlled trial that compares the clinical effectiveness of a combination of manual therapy and exercise to exercise therapy only will be conducted.

NCT ID: NCT00661206 Active, not recruiting - Clinical trials for Coronary Artery Disease

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting

ISAR-SAFE
Start date: September 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether a 6 month duration of clopidogrel therapy after DES implantation is not inferior to that of a 12 month therapy.

NCT ID: NCT00594828 Active, not recruiting - Warfarin Clinical Trials

Patient Self Testing of Warfarin Therapy

Start date: July 2006
Phase: Phase 4
Study type: Interventional

To test the hypothesis that home international normalised ratio (INR) monitoring with supervised patient self-testing (PST)can provide comparable or superior time in therapeutic range (TTR) to that provided by traditional outpatient anticoagulation.

NCT ID: NCT00510978 Active, not recruiting - Ulcerative Colitis Clinical Trials

Probiotics in GastroIntestinal Disorders

PROGID
Start date: January 2002
Phase: Phase 2/Phase 3
Study type: Interventional

All of us have millions of bacteria living in our gut. These bacteria are very important to our health providing us with protection against infections of the gut, allowing us to gain extra nutritional value from food we eat and helping our immune system. Changes in the balance of these many bacteria can make us vulnerable to infections both from within and from outside the gut. Certain bacteria may also be directly associated with some diseases of the gut. Research by doctors and scientists into relationships between the bacteria normally found in our gut and certain diseases of the gut is helping to develop food supplements and other therapies to treat these diseases. This study involves research into the usefulness and safety of two probiotic products in maintaining remission in Crohn's disease and ulcerative colitis. Approximately 360 patients with Crohn's disease and ulcerative colitis from Ireland, Finland and Spain will be involved in the study. The yoghurts used in this study contain either Lactobacillus salivarius subsp. salivarius or Bifidobacterium infantis.

NCT ID: NCT00470236 Active, not recruiting - Clinical trials for Carcinoma, Ductal, Breast

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast

DCIS
Start date: June 2007
Phase: N/A
Study type: Interventional

Hypotheses: 1. The addition of tumour bed boost after BCS in women with non-low risk DCIS reduces the risk of local recurrence (invasive or intraductal recurrence in the ipsilateral breast). 2. The risk of local recurrence in the shorter fractionation arm is not worse than that for the standard fractionation arm. 3. A molecular signature predictive of invasive recurrence of DCIS will be detectable and the molecular signature may eventually have clinical utility for therapy individualization. Overall Objectives: 1. To improve the outcome of women with non-low risk DCIS treated with breast conserving therapy. 2. To individualize treatment selection for women with DCIS to achieve long term disease control with minimal toxicity.

NCT ID: NCT00454389 Active, not recruiting - Clinical trials for Macular Degeneration

A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

CABERNET
Start date: April 2007
Phase: Phase 3
Study type: Interventional

The objective of the CABERNET Trial is to evaluate the safety and efficacy of focal delivery of radiation for the treatment of subfoveal choroidal neovascularization (CNV) associated with wet age-related macular degeneration (AMD). The Epi-Rad90™ Ophthalmic System treats neovascularization of retinal tissue by means of a focal, directional delivery of radiation to the target tissues in the retina. Using standard vitreoretinal surgical techniques, the sealed radiation source is placed temporarily over the retinal lesion by means of a handheld medical device.

NCT ID: NCT00405756 Active, not recruiting - Clinical trials for Newly Diagnosed Multiple Myeloma

A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.

Start date: January 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether lenalidomide is safe and effective in the treatment of patients with newly diagnosed Multiple Myeloma who are 65 years of age or older.

NCT ID: NCT00391612 Active, not recruiting - Emphysema Clinical Trials

EASE Trial: Exhale Airway Stents for Emphysema

EASE
Start date: May 2006
Phase: Phase 3
Study type: Interventional

This is an international clinical research study evaluating the safety and effectiveness of a new procedure called airway bypass. The goal of this research is to see if airway bypass can relieve hyperinflation (overfilling) of the lungs, thereby improving lung function and reducing shortness of breath in patients with severe homogeneous (diffuse) emphysema. "EASE" stands for Exhale Airway Stents for Emphysema.

NCT ID: NCT00382070 Active, not recruiting - Breast Cancer Clinical Trials

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Start date: August 2006
Phase: Phase 3
Study type: Interventional

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. It is not yet known whether letrozole is more effective than a placebo in treating patients with hormone receptor-positive breast cancer. PURPOSE: This randomized phase III trial is studying letrozole to see how well it works compared with a placebo in treating postmenopausal women who have received hormone therapy for hormone receptor-positive breast cancer.

NCT ID: NCT00360945 Active, not recruiting - Clinical trials for Brain and Central Nervous System Tumors

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

Start date: April 2004
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as cisplatin and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving cisplatin together with temozolomide works in treating young patients with malignant glioma.